Biomarck Pharmaceuticals to Present Expanded Analysis of BIO-11006 Clinical Data in Treatment of Non-Small Cell Lung Cancer at the American Thoracic Society 2020 International Conference
By Biomarck
Press
Biomarck Announces, Phase 2a Clinical Trial Results of BIO-11006 for Acute Respiratory Distress Syndrome (ARDS)
By Biomarck
Biomarck Pharmaceuticals to Participate in 38th Annual J.P. Morgan
Healthcare Conference on Thursday, January 16th, 2020
By Biomarck
After daughter’s cancer death, family supports experimental treatment developed in Triangle
By Maggie Newland
Biomarck announces statistically significant results from the Phase 2 controlled clinical study in non small cell lung cancer (NSCLC)
BioMarck
Biomarck Announces the start of a Phase 2 Clinical Trial of BIO-11006 for Non-
Small Cell Lung Cancer (NSCLC)
BioMarck
Biomarck Announces First Patients Treated in Phase 2 Clinical Trial of BIO-
11006 for Acute Respiratory Distress Syndrome (ARDS)
BioMarck
Groundbreaking Cancer Research, Decades in the Making
By Jordan Bartel/NC State Veterinary Medicine
South Florida Connection To Possible Cancer Miracle Drug
CBS Miami’s Gary Nelson reports from Hialeah.
After daughter’s cancer death, family supports experimental treatment developed in Triangle
By Maggie Newland
